Oyonarte Miguel, Montagna Rodrigo, Braun Sandra, Rojo Pamela, Jara José L, Cereceda Mauricio, Morales Marcelo, Nazzal Carolina, Alonso Faustino
Centro Cardiovascular, Hospital Clínico San Borja Arriarán, Universidad de Chile, Chile.
Rev Med Chil. 2012 Dec;140(12):1517-28. doi: 10.4067/S0034-98872012001200001.
Rates of morbidity and mortality in Infective Endocarditis (IE) remain high and prognosis in this disease is still difficult and uncertain.
To study IE in Chile in its active phase during inpatient hospital stay and long term survival rates.
Observational prospective national cohort study of 506 consecutive patients included between June 1,1998 and July 31, 2008, from 37 Chilean hospitals (secondary and tertiary centers) nationwide.
The main findings were the presence of Rheumatic valve disease in 22.1 % of patients, a history of intravenous drug abuse (IVDA) only in 0.7%, the presence of Staphylococcus aureus in 29.2% of blood cultures, negative blood cultures in 33.2%, heart failure in 51.7% and native valve involvement in 86% of patients. Echocardiographic diagnosis was achieved in 94% of patients. Hospital mortality was 26.1% and its prognostics factors were persisting infection (Odds ratio (OR) 6.43, Confidence Interval (CI) 1.45-28.33%), failure of medical treatment and no surgical intervention (OR 48.8; CI 6.67-349.9). Five and 10 years survival rates were 75.6 and 48.6%, respectively. The significant prognostic factors for long term mortality, determined by multivariate analysis were the presence of diabetes, Staphylococcus aureus infection, sepsis, heart failure, renal failure and lack of surgical treatment during the IE episode.
The microbiologic diagnosis of IE must be urgently improved in Chile. Mortality rates are still high (26.1%) partly because of a high incidence of negative blood cultures and the need for more surgical valve interventions during in-hospital period. Long term prognostic factors for mortality should be identified early to improve outcome.
感染性心内膜炎(IE)的发病率和死亡率仍然很高,这种疾病的预后仍然困难且不确定。
研究智利住院期间处于活动期的IE及其长期生存率。
对1998年6月1日至2008年7月31日期间全国37家智利医院(二级和三级中心)连续收治的506例患者进行观察性前瞻性队列研究。
主要发现包括22.1%的患者存在风湿性瓣膜病,仅0.7%的患者有静脉药物滥用史,29.2%的血培养中发现金黄色葡萄球菌,33.2%的血培养结果为阴性,51.7%的患者出现心力衰竭,86%的患者累及自身瓣膜。94%的患者通过超声心动图得到诊断。医院死亡率为26.1%,其预后因素包括持续感染(比值比(OR)6.43,置信区间(CI)1.45 - 28.33%)、药物治疗失败且未进行手术干预(OR 48.8;CI 6.67 - 349.9)。5年和10年生存率分别为75.6%和48.6%。多因素分析确定的长期死亡率的显著预后因素包括糖尿病、金黄色葡萄球菌感染、脓毒症、心力衰竭、肾衰竭以及IE发作期间未进行手术治疗。
智利必须紧急改善IE的微生物学诊断。死亡率仍然很高(26.1%),部分原因是血培养阴性的发生率较高以及住院期间需要更多的外科瓣膜干预。应尽早确定长期死亡率的预后因素以改善结局。